Articles
Oral cannabidiol did not impair learning and memory in healthy adults - Journal of Cannabis Research
Jan 22, 2025 |
jcannabisresearch.biomedcentral.com | ICON plc |San Antonio
Information regarding the demographics of study participants is provided in Table 2. Among the 35 study participants retained for the analyses, 19 were female (54%) and the majority were between the ages of 18–27 (71.4%). The age of participants ranged from 18 to 64, with only four participants over 60. Most completed some college (49/2%) and 18 (51/4%) of the subjects self-identified as Caucasian.
-
Oct 23, 2024 |
app.researchpool.com | ICON plc
DUBLIN--(BUSINESS WIRE)-- (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the third quarter ended September 30, 2024. CEO, Dr. Steve Cutler commented, “ICON’s results for the third quarter did not meet the expectations we had previously provided due to specific customer and division-level impacts.
-
May 2, 2024 |
frontiersin.org | ICON plc
Hospital Civil de Guadalajara "Dr. Juan I.
-
Jan 5, 2024 |
app.researchpool.com | ICON plc
DUBLIN--(BUSINESS WIRE)--, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 5:15pm PST/8.15pm EST. Any changes to these events and links to the live webcasts (where available) will be posted on the Investor section of our website under “”.
-
Jul 13, 2023 |
app.researchpool.com | ICON plc
, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has received positive recognition from leading business and industry organisations as a leading CRO of choice and a top-rated employer in the first half of 2023. For its excellent performance in clinical research, ICON was named a recipient of the 2023 CRO Leadership Awards in the following categories: Capabilities, Compatibility, Expertise, Quality and Reliability.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →